Healthcare provider knowledge, attitudes, and preferences in management of genitourinary syndrome of menopause in the Mid-South

被引:6
作者
Morris, Joshua [1 ]
Clark, Cassidy [1 ]
Reed, Laura [2 ]
Pace, Diane [1 ,2 ]
Cao, Xueyuan [2 ]
Khanna, Pallavi [1 ]
机构
[1] Univ Tennessee, Dept Obstet & Gynecol, Hlth Sci Ctr, Memphis, TN 38103 USA
[2] Univ Tennessee, Coll Nursing, Hlth Sci Ctr, Memphis, TN 38103 USA
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2021年 / 28卷 / 11期
关键词
Genitourinary syndrome of menopause; Menopause; Vaginal estrogen; Vulvar and vaginal symptoms; DOSE VAGINAL ESTROGEN; POSTMENOPAUSAL WOMEN; HORMONE-THERAPY; ATROPHY; PATTERNS; SOCIETY; VULVAR; VIEWS;
D O I
10.1097/GME.0000000000001847
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study explored the clinical management practices of healthcare providers who treat menopausal women in an urban Mid-South area. The study specifically examined their knowledge of prescribing and counseling related to the care of women who present with complaints or clinical findings of genitourinary syndrome of menopause. Methods: An electronic questionnaire was distributed to healthcare providers involved in the care of women undergoing menopausal transition spanning a variety of medical specialties. The questionnaire was distributed to academic program directors, coordinators, and ListServ administrators to forward to targeted respondents. Items included demographic questions, clinical knowledge, management practices, and preferences. Statistical analysis for associations between demographics was performed using Chi-squared tests and between age groups with Kruskal Wallis tests. Results: The final sample contained 106 healthcare providers. Respondents were demographically diverse and encompassed multiple levels of professional training including Attendings, Trainees (Residents and Fellows), as well as Advanced Practice Registered Nurses. Significant differences were noted in many areas examined in our questionnaire, comprising knowledge, management, counseling, and prescribing practices surrounding the treatment of genitourinary syndrome of menopause when accounting for training level, specialty, and years in practice. Among all respondents, 10.4% reported rarely or never discussing menopausal symptoms with their patients. Most respondents (76.4%) stated they had prescribed topical therapies for genitourinary syndrome of menopause, with over 90% of practitioners prescribing lubricants/moisturizers and estradiol cream; however, only 55% reported being familiar with the US Food and Drug Administration's boxed warning on low-dose vaginal estrogen. Nearly half of the respondents (49%) reported being uncomfortable counseling about the boxed warning on low-dose vaginal estrogen. Conclusion: This study identifies gaps in Mid-South healthcare providers' awareness of the boxed warning on low-dose vaginal estrogen as well as their comfort level in providing counseling regarding the risks, benefits, and alternatives to vaginal estrogen. Integrated practice between physicians and Advanced Practice Registered Nurses can lead to a significant benefit to patients experiencing menopause as shared experience and knowledge are shared between each group. Our survey does reveal gaps in knowledge and practice for optimal outcomes for patients experiencing genitourinary syndrome of menopause. These results will be useful in providing continuing education to providers and more effective communication, evaluation, and treatment to patients.
引用
收藏
页码:1239 / 1246
页数:8
相关论文
共 35 条
  • [1] The role of microbiota in the management of genitourinary syndrome of menopause
    Stabile, G.
    Topouzova, G. A.
    De Seta, F.
    CLIMACTERIC, 2023, 26 (04) : 353 - 360
  • [2] Current challenges in the pharmacological management of genitourinary syndrome of menopause
    Salvatore, Stefano
    Benini, Vittoria
    Ruffolo, Alessandro Ferdinando
    Degliuomini, Rebecca S.
    Redaelli, Anna
    Casiraghi, Arianna
    Candiani, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (01) : 23 - 28
  • [3] Update on management of genitourinary syndrome of menopause: A practical guide
    Palacios, Santiago
    Castelo-Branco, Camil
    Currie, Heather
    Mijatovic, Velja
    Nappi, Rossella E.
    Simon, James
    Rees, Margaret
    MATURITAS, 2015, 82 (03) : 308 - 313
  • [4] Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study
    Baquedano Mainar, Laura
    Sanchez Mendez, Sonia
    Dieste Perez, Pena
    Hernandez Aragon, Monica
    Ladron de Guevara, Nicolas Mendoza
    BMC WOMENS HEALTH, 2021, 21 (01)
  • [5] Urologic view in the management of genitourinary syndrome of menopause
    Wasserman, M. C.
    Rubin, R. S.
    CLIMACTERIC, 2023, 26 (04) : 329 - 335
  • [6] Genitourinary Syndrome of Menopause: Management Strategies for the Clinician
    Faubion, Stephanie S.
    Sood, Richa
    Kapoor, Ekta
    MAYO CLINIC PROCEEDINGS, 2017, 92 (12) : 1842 - 1849
  • [7] Modern management of the genitourinary syndrome of menopause (GSM)
    Stute, Petra
    THERAPEUTISCHE UMSCHAU, 2021, 78 (08) : 413 - 420
  • [8] Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause
    Stute, P.
    Bertschy, S.
    Birkhaeuser, M.
    Bitzer, J.
    Ging, A.
    Raggi, A.
    Steimann, S.
    Stute, V
    CLIMACTERIC, 2022, 25 (03) : 246 - 256
  • [9] Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause
    Kagan, Risa
    Kellogg-Spadt, Susan
    Parish, Sharon J.
    DRUGS & AGING, 2019, 36 (10) : 897 - 908
  • [10] The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM)
    Lin, Kun-Ling
    Chou, Shih-Hsiang
    Loo, Zi-Xi
    Liu, Yi-Yin
    Cheng, Jung-Chien
    Long, Cheng-Yu
    LASERS IN MEDICAL SCIENCE, 2022, 37 (04) : 2203 - 2208